Riluzole and other prognostic factors in ALS: a population-based registry study in Italy

In this prospective population-based registry study on ALS survival, we investigated the role of riluzole treatment, together with other clinical factors, on the prognosis in incident ALS cases in Emilia Romagna Region, Italy

Jessica Mandrioli

2018

Scholarcy highlights

  • A registry for ALS has been collecting all incident cases in Emilia Romagna Region since 2009
  • In this prospective population-based registry study on ALS survival, we investigated the role of riluzole treatment, together with other clinical factors, on the prognosis in incident ALS cases in Emilia Romagna Region, Italy
  • Detailed clinical data from all patients diagnosed with ALS between 1.1.2009 and 31.12.2014 have been analyzed for this study, with last follow up date set at 31.12.2015
  • From other prognostic factors, patients who received riluzole for a longer period of time survived longer, but further population based studies are needed to verify if long-tem use of riluzole prolongs survival

Need more features? Save interactive summary cards to your Scholarcy Library.